Filing Details
- Accession Number:
- 0001387131-14-003915
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-24 21:33:33
- Reporting Period:
- 2014-11-20
- Filing Date:
- 2014-11-24
- Accepted Time:
- 2014-11-24 21:33:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532231 | A Daniel Cartwright | 6800 Broken Sound Parkway Nw, Third Floor Boca Raton FL 33487-3507 | Cfo, Vp Finance, Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-20 | 40,000 | $0.38 | 40,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-20 | 20,000 | $3.88 | 20,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-21 | 20,000 | $3.93 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified stock | Disposition | 2014-11-20 | 40,000 | $0.00 | 40,000 | $0.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 260,000 | 2012-10-21 | 2021-10-21 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to a 10b5-1 Sales Plan dated September 8, 2014.
- The options were exercised and the price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $3.82 to $3.93, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $3.85 to $4.00, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
